Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 872 of 1,261
  1. US 8440210

    Stabilized pharmaceutical product

    TAKEDA GMBH · Granted May 14, 2013 · Expires May 9, 2033

    granted
  2. US 8440206

    Methods for producing an immune response to tuberculosis

    The United States of America as represented by the Department of Veteran Affairs · Granted May 14, 2013 · Expires May 9, 2033

    granted
  3. US 8440229

    Hollow silica nanospheres and methods of making same

    The Regents of the University of California · Granted May 14, 2013 · Expires May 9, 2033

    granted
  4. US 8440621

    Analogs of ShK toxin and their uses in selective inhibition of Kv1.3 potassium channels

    The Regents of the University of California · Granted May 14, 2013 · Expires May 9, 2033

    granted
  5. US 8440689

    Fused heteroaromatic pyrrolidinones

    Takeda Pharmaceutical Company Limited · Granted May 14, 2013 · Expires May 9, 2033

    granted
  6. US 8440739

    Dental composition and composite resin

    JGC Catalysts and Chemicals Ltd. · Granted May 14, 2013 · Expires May 9, 2033

    granted
  7. US 8440309

    Crosslinked polymers with the crosslinker as therapeutic for sustained release

    Covidien LP · Granted May 14, 2013 · Expires May 9, 2033

    granted
  8. US 8440393

    Pro-angiogenic genes in ovarian tumor endothelial cell isolates

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 14, 2013 · Expires May 9, 2033

    granted
  9. US 8440411

    Differential gene expression in physiological and pathological angiogenesis

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 14, 2013 · Expires May 9, 2033

    granted
  10. US 8440415

    BORIS isoforms and methods of detecting and treating disease

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted May 14, 2013 · Expires May 9, 2033

    granted
  11. US 8440431

    TAL effector-mediated DNA modification

    Regents of the University of Minnesota · Granted May 14, 2013 · Expires May 9, 2033

    granted
  12. US 8440432

    Tal effector-mediated DNA modification

    Regents of the University of Minnesota · Granted May 14, 2013 · Expires May 9, 2033

    granted
  13. US 8440614

    Polymer microspheres/nanospheres and encapsulating therapeutic proteins therein

    Aphios Corporation · Granted May 14, 2013 · Expires May 9, 2033

    granted
  14. US 8440623

    Polymer stabilized neuropeptides

    Nektar Therapeutics · Granted May 14, 2013 · Expires May 9, 2033

    granted
  15. US 8440618

    Composition for the attachment of implants to collagen or other components of biological tissue

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted May 14, 2013 · Expires May 9, 2033

    granted
  16. US 8440168

    Image-guided therapy of myocardial disease: composition, manufacturing and applications

    The Board of Regents of the University of Texas System · Granted May 14, 2013 · Expires May 9, 2033

    granted
  17. US 8440182

    Methods and compositions for treating phenylketonuria

    The Board of Regents of the University of Texas System · Granted May 14, 2013 · Expires May 9, 2033

    granted
  18. US 8440208

    Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease

    The Board of Regents of the University of Texas System · Granted May 14, 2013 · Expires May 9, 2033

    granted
  19. US 8440205

    Streptococcal C5A peptidase vaccine

    Regents of the University of Minnesota · Granted May 14, 2013 · Expires May 9, 2033

    granted
  20. US 8436014

    Solid forms of N-(4-(7-azabicyclo[2.2.1]heptan-7-yl)-2-(trifluorormethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihyroquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted May 7, 2013 · Expires May 2, 2033

    granted
  21. US 8436043

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted May 7, 2013 · Expires May 2, 2033

    granted
  22. US 8436200

    Process for making (R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-flouro-4- iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione and intermediates thereof

    Takeda Pharmaceutical Company Limited · Granted May 7, 2013 · Expires May 2, 2033

    granted
  23. US 8436154

    Crystallizing method of erythromycin

    SUNSHINE LAKE PHARMA CO., LTD. · Granted May 7, 2013 · Expires May 2, 2033

    granted
  24. US 8435943

    Protein stabilization formulations

    Advanced Technologies and Regenerative Medicine, LLC · Granted May 7, 2013 · Expires May 2, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.